Zindoxifene is a partial antiestrogen that inhibits the growth of estrogen-dependent tumor cells by binding to estrogen receptors; it exhibits both estrogenic agonist and antagonist activities and is used in research on estrogen-dependent cancers, such as prostate cancer and breast cancer.